COPD Maintenance Drug Approved by FDA | ThirdAge

Links shared publicly online about this topic.

  • 470
    total visits

COPD Maintenance Drug Approved by FDA | ThirdAge

thirdage.com

The FDA approved the first oral anti-inflammatory treatment for chronic obstructive pulmonary disease. The once-a-day tablet, DalirespTM (roflumilast), helps reduce lung functions for OCPD patients who experience breathlessness, chronic cough and

View full resource at thirdage.com

Tags: Lung, COPD, Disease and Condition, Drug, FDA, Pulmonology, disease

  • Share

Most Recently Shared on March 1, 2011 at 9:00 pm By:

thirdagetimes ThirdAge.com

COPD Maintenance Drug Approved by FDA http://bit.ly/eJUK5k

1 year ago...

FDA Approves Arcapta Neohaler To Treat Chronic Obstructive Pulmonary Disease - QualityPoint Technologies

qualitypointtech.net — “The U.S. Food and Drug Administration approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema. COPD is a serious lung disease that makes breathing difficult. Symptoms can include breathlessness, chronic cough and excessive phlegm...View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 3, 2011 at 8:45 am By:

MedicalFeed MedicalFeed Health News Feed

FDA Approves Arcapta Neohaler To Treat Chronic Obstructive Pulmonary Disease: The U.S. Food and Drug Administratio... http://bit.ly/iCpKuD

11 months ago...

Novartis Announces FDA Approval For Arcapta To Treat COPD Symptoms

rttnews.com — “Novartis AG (NVS), Friday announced that the US Food and Drug Administration has approved once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg for the long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.View full resource at rttnews.com

  • View Related
  • Share

Most Recently Shared on July 2, 2011 at 2:30 am By:

wheezemd Michael Blaiss, MD Doctor, Allergist, and Physician

Novartis Announces FDA Approval For Arcapta To Treat COPD Symptoms, once a day bronchodilator - http://goo.gl/cd9hS

11 months ago...

New Inhaler Drug for COPD Approved - QualityPoint Technologies

qualitypointtech.net — “WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, the agency announced.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 11:00 pm By:

MedicalFeed MedicalFeed Health News Feed

New Inhaler Drug for COPD Approved: WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol... http://bit.ly/iGWeAq

11 months ago...

Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, thView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 10:13 pm By:

Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, thView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 10:11 pm By:

Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 5:28 pm By:

Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 4:50 pm By:

Advertisement